GREAT POINT PARTNERS LLC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 115 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
GREAT POINT PARTNERS LLC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$7,635,000
+20.6%
1,500,000
+50.0%
1.78%
+33.9%
Q2 2021$6,330,000
-47.5%
1,000,000
-31.0%
1.33%
+37.6%
Q2 2020$12,067,000
+1025.7%
1,448,604
+936.8%
0.96%
+761.6%
Q1 2020$1,072,000
-89.6%
139,718
-85.4%
0.11%
-89.0%
Q1 2019$10,310,000959,0771.02%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
BVF INC/IL 1,877,148$13,853,0001.46%
Congress Park Capital LLC 167,811$1,238,0001.04%
Perceptive Advisors 3,253,923$24,014,0000.65%
RTW INVESTMENTS, LP 990,463$7,310,0000.44%
Spark Investment Management LLC 337,164$2,488,0000.32%
Exane Asset Management 54,065$399,000,0000.31%
DAFNA Capital Management LLC 100,000$738,0000.28%
HARBOURVEST PARTNERS LLC 79,193$584,0000.24%
WELD CAPITAL MANAGEMENT LLC 86,363$637,0000.12%
GSA CAPITAL PARTNERS LLP 77,997$576,0000.08%
View complete list of CYTOMX THERAPEUTICS INC shareholders